Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05185687 · ClinicalTrials.gov registry record · NA
Public Support for COVID-19 Test Allocation
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 2,019
- Enrollment target
NCT05185687: Completed NA study, sponsored by University of Pennsylvania.
NCT05185687 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 2,019 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05185687, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,019 participants
- Enrollment target
Study Summary
In a randomized survey experiment, investigators will assess public support or opposition towards one of three potential government plans for allocating at-home coronavirus disease 2019 (COVID-19) tests to United States residents: 1) first come, first served; 2) a random draw; or 3) a random draw with 20% of tests reserved for disadvantaged areas. Investigators will also examine public attitudes surrounding other logistical and equity-related aspects of these allocation plans.
Interventions
- BEHAVIORAL First Come, First Served
- BEHAVIORAL Random
- BEHAVIORAL Disadvantaged Priority & Random
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,019 participants |
| Start Date | 2022-01-04 |
| Est. Completion | 2022-01-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05185687
The ClinicalTrials.gov registry entry for NCT05185687 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,019 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which First Come, First Served is the first listed.
NCT05185687 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05185687 about?
NCT05185687 is a clinical study titled "Public Support for COVID-19 Test Allocation". In a randomized survey experiment, investigators will assess public support or opposition towards one of three potential government plans for allocating at-home coronavirus disease 2019 (COVID-19) tests to United States residents: 1) first come, first served; 2) a random draw; or 3) a random draw wi...
What is the current status of trial NCT05185687?
This trial is currently completed. It is a NA study. The enrollment target is 2,019 participants. The study started on 2022-01-04. Estimated completion is 2022-01-06.
What interventions are being tested in trial NCT05185687?
The interventions under investigation include: First Come, First Served (BEHAVIORAL), Random (BEHAVIORAL), Disadvantaged Priority & Random (BEHAVIORAL).
Who is sponsoring clinical trial NCT05185687?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.